Pathophysiology and markers of very early classic Guillain-Barré syndrome
September 2024
Guillain-Barré syndrome is a rare neurological disorder characterized by the body's immune system mistakenly attacking the peripheral nerves. This condition often follows an infection and can lead to...
Early detection of autism with the help of biomarkers: A narrative review
September 2025
Autism spectrum disorder is a neurodevelopmental disorder with symptoms that vary significantly in individuals. The main manifestations include difficulties in social interactions, communication disorders,...
Understanding Vivaldi's cognitive and neurobiological effects through behavioral and neuroimaging biomarker lenses: A narrative review
Available online 5 November 2025
Research has demonstrated that Antonio Vivaldi's Four Seasons concertos boost attention and working memory in young and older populations. Neuroimaging biomarkers derived from electroencephalography,...
Blood biomarkers for clinical applications in Alzheimer's disease: A narrative review
June 2025
Alzheimer's disease is a prevalent neurodegenerative disorder that imposes a significant burden on both patients and society. Currently, the primary methods for diagnosing Alzheimer’s disease include...
Biases and consistency of different assay methods for neurological biomarkers using Quanterix single-molecule-array technology: A comparative study of the secondary analysis method
March 2026
Breakthrough technologies such as the Single molecule array (Simoa) technology developed by Quanterix provide higher sensitivity, enabling measurement of central nervous system-abundant proteins in...
Misdiagnoses of psychiatric disorders and the utility of diagnostic microRNA biomarkers
September 2024
Due to overlapping symptoms and similarities with other illnesses, misdiagnosis and inappropriate treatment of psychiatric disorders frequently occur. Objective laboratory-based biomarkers that can...
Role of the amygdala and possible biomarkers in psychiatric disorders
March 2025
In the early 1800s, the "cerebral amygdala" was described as an almond-shaped structure within the temporal lobe. A century later, the role of amygdala in modulating behavior became evident, specifically...
Biomarkers in autoimmune myasthenia gravis: A narrative review
September 2025
Myasthenia gravis is a heterogeneous, autoimmune disease of the neuromuscular junction, characterized by fatigable muscle weakness. Early diagnosis is critical to initiate immunotherapy for the disease,...
Role of gut-microbiome-brain axis in neurodegenerative diseases: A narrative review of mechanisms, therapeutics, and emerging perspectives
September 2025
The gut–microbiota–brain axis represents a complex bidirectional communication system linking intestinal microbes and their metabolites with the central nervous system. Growing evidence suggests that...
Neurobiological and neuroimaging biomarkers: A narrative review of precision medicine for diagnosing neurodegenerative disorders
Available online 23 December 2025
Markers provide information about brain function, structure, and activity and are often used to study neurological and psychiatric conditions. This is crucial for diseases such as Parkinson’s disease,...
Blood-based biomarkers for neurodegenerative diseases: A narrative review
Available online 31 March 2026
Blood-based biomarkers have revolutionized the diagnostic landscape for neurodegenerative diseases, offering accessible alternatives to invasive cerebrospinal fluid analysis and expensive neuroimaging....
Neuromarkers in bipolar disorder: A narrative review bridging neuroscience and clinical practice
June 2026
Bipolar disorder is a chronic, disabling psychiatric condition characterized by recurrent mood episodes and substantial functional impairment. Its diagnosis and management remain largely reliant on...
Optimizing Alzheimer's diagnosis and precision medicine: A narrative review unlocking the potential of multiomics markers
September 2025
Alzheimer’s disease (AD) is a complex neurodegenerative disorder characterized by progressive cognitive and functional decline, with significant societal and economic consequences. Its differential...
Biomarkers for diabetic peripheral neuropathy: A narrative review of advanced glycation end products
Available online 22 December 2025
The pathophysiology of diabetic neuropathy involves hyperglycemia-induced metabolic changes, including the polyol and protein kinase C pathways and the formation of advanced glycation end products (AGEs)....
Brain age prediction from MRI scans using deep learning: A robust multi-site framework for neurodegenerative disease biomarker development
Available online 18 February 2026
Brain age prediction has emerged as a promising computational biomarker for understanding healthy aging and identifying deviations associated with neurodegenerative diseases. This study constructed...
The role of machine learning in discovering biomarkers and predicting treatment strategies for neurodegenerative diseases: A narrative review
March 2025
Machine learning in the field of computational intelligence continues to increase significantly and shows potential in the identification, management, treatment, and monitoring of complex diseases,...
Apolipoprotein E genotype as a biomarker in late-onset Alzheimer’s disease: A narrative review of the influence of genetic factors on molecular structure
September 2025
Late-onset Alzheimer's disease is the leading cause of dementia in the elderly. The pathophysiology of the disease is complex and its pathogenesis remains to be elucidated. This review addresses the...
Brain structural and functional alteration in movement disorders: A narrative review of markers and their dynamic changes
March 2026
Movement disorders can present a significant challenge to healthcare professionals due to their varied etiologies, complex symptomatology, and often debilitating consequences for patients by affecting...
Grip force variability and deep learning: A cross-sectional study of a novel biomarker for early detection of Parkinson's disease
September 2025
Accurately distinguishing Parkinson’s disease (PD) from healthy aging remains challenging, especially using noninvasive methods. When analyzed with advanced computational methods, grip force variability...
Glial fibrillary acidic protein as a biomarker for diagnosis of Alzheimer’s disease in cerebrospinal fluid, plasma and saliva measured with Lumipulse technology: a narrative review
March 2025
Glial fibrillary acidic protein is an intermediate filament protein released primarily by astrocytes in the central nervous system, providing structural and functional support to neurons. Glial fibrillary...
Imaging biomarkers for the diagnosis of corticobasal ganglia syndrome: DaTSCAN and [18F]FDG PET
September 2025
Corticobasal syndrome is a complex neurodegenerative disorder with clinical features that overlap with other Parkinsonian syndromes, posing significant diagnostic challenges. Biomarkers are essential...
Expanding landscape of tau pathology in neurological disorders: A narrative review guiding diagnostic development and targeted therapeutics
Available online 31 March 2026
For decades, tau pathology was synonymous with Alzheimer’s disease, where it co-occurs with amyloid-β plaques. A paradigm shift has since established that tau is the primary pathogenic driver of a diverse...
Fractal dimension reveals cellular morphological changes as early biomarkers in neurodegenerative diseases: A narrative review
September 2025
Fractal dimension has emerged as a powerful tool for capturing structural irregularities and self-similar patterns in biological tissues, providing crucial insights beyond traditional morphological...
Integrating multimodal biomarker strategies: A narrative review of molecular and characteristic imaging techniques for better monitoring of neurodegenerative diseases
June 2026
Neurodegenerative disorders, such as Parkinson’s disease, Alzheimer’s disease, amyotrophic lateral sclerosis, Huntington’s disease, multiple sclerosis, neurofibromatosis, represent a diverse group of...
New insights into neurofilament and cytokine biomarkers: A narrative review
June 2026
Guillain–Barré syndrome and chronic inflammatory demyelinating polyneuropathy are immune-mediated neuropathies that often present with clinical uncertainty. Early and accurate diagnosis of these conditions...